Long-Term Follow Up of Patients Receiving Novel Gene Therapy for SMA Type I

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.